We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$60.9B
AUM Growth
-$821M
(-1.3%)
Cap. Flow
-$3.18B
Cap. Flow
% of AUM
-5.23%
Top 10 Holdings %
Top 10 Hldgs %
24.34%
Holding
1,619
New
432
Increased
351
Reduced
430
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSX Corp
CSX
|
+$487M |
| 2 |
Kimberly-Clark
KMB
|
+$223M |
| 3 |
Norfolk Southern
NSC
|
+$217M |
| 4 |
Boeing
BA
|
+$167M |
| 5 |
Caterpillar
CAT
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YPF
YPF
|
+$362M |
| 2 |
ICICI Bank
IBN
|
+$270M |
| 3 |
Chevron
CVX
|
+$239M |
| 4 |
AABA
Altaba Inc
AABA
|
+$238M |
| 5 |
Citizens Financial Group
CFG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 15.67% |
| 3 | Financials | 13.22% |
| 4 | Industrials | 13.12% |
| 5 | Communication Services | 10.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRCL
126
DELISTED
Stericycle Inc
SRCL
| $92.2M | 0.15% |
1,811,211
+293,299
| +19% | +$13.6M |
|
|
NLSN
127
DELISTED
Nielsen Holdings plc
NLSN
| $90.8M | 0.15% |
4,274,551
+1,048,127
| +32% | +$23.1M |
|
128
Citigroup
C
$222B
| $88M | 0.14% |
1,273,640
+28,518
| +2% | +$1.94M |
|
129
Nike
NKE
$62.7B
| $85.5M | 0.14% |
909,984
+306,134
| +51% | +$26.3M |
|
130
KB Financial Group
KB
$42.5B
| $83.7M | 0.14% |
2,343,311
+53,291
| +2% | +$1.88M |
|
131
H&R Block
HRB
$5.61B
| $79.9M | 0.13% |
3,382,928
+1,135,343
| +51% | +$30M |
|
|
CAF
132
Morgan Stanley China A Share Fund
CAF
$325M
| $79.9M | 0.13% |
3,903,420
+637,958
| +20% | +$13.5M |
|
133
Hershey
HSY
$35.9B
| $78.6M | 0.13% |
507,248
+257,724
| +103% | +$38.9M |
|
134
Meta Platforms (Facebook)
META
$1.37T
| $78.6M | 0.13% |
441,451
+32,516
| +8% | +$6.18M |
|
135
Bank of America Series L
BAC.PRL
$3.96B
| $78.3M | 0.13% |
52,252
+270
| +0.5% | +$386K |
|
136
Cognex
CGNX
$10.4B
| $78.2M | 0.13% |
1,592,100
| – | – |
|
137
Boston Scientific
BSX
$68.4B
| $77.2M | 0.13% |
1,896,759
-29,955
| -2% | -$1.27M |
|
138
BHP
BHP
$218B
| $76.9M | 0.13% |
1,746,006
-23,179
| -1% | -$1.08M |
|
|
SPLK
139
DELISTED
Splunk Inc
SPLK
| $76.6M | 0.13% |
649,548
+4,082
| +0.6% | +$510K |
|
140
IBM
IBM
$209B
| $76M | 0.12% |
546,729
+285,748
| +109% | +$38.5M |
|
141
Microchip Technology
MCHP
$40.7B
| $75.9M | 0.12% |
1,634,000
-2,224
| -0.1% | -$101K |
|
142
Pediatrix Medical
MD
$2.17B
| $73.5M | 0.12% |
3,249,877
+992,282
| +44% | +$22.6M |
|
143
Qiagen
QGEN
$8.55B
| $71.9M | 0.12% |
2,056,145
| – | – |
|
144
Colgate-Palmolive
CL
$73.3B
| $70.6M | 0.12% |
960,305
+364,124
| +61% | +$26.4M |
|
145
Omnicom Group
OMC
$21.8B
| $68.6M | 0.11% |
876,583
+118,262
| +16% | +$9.39M |
|
|
CLGX
146
DELISTED
Corelogic, Inc.
CLGX
| $68.4M | 0.11% |
1,478,073
-288,867
| -16% | -$13.3M |
|
147
3M
MMM
$90.8B
| $67.9M | 0.11% |
494,236
+390,981
| +379% | +$54.7M |
|
148
Brixmor Property Group
BRX
$9.67B
| $65.3M | 0.11% |
3,217,503
-23,980
| -0.7% | -$451K |
|
149
Cognizant
CTSH
$24.3B
| $64.7M | 0.11% |
1,074,405
+678,193
| +171% | +$42.9M |
|
|
CEO
150
DELISTED
CNOOC Limited
CEO
| $64M | 0.11% |
420,473
-14,907
| -3% | -$2.35M |
|
Similar funds
QCM
Lazard Asset Management's Q3 2019 Portfolio in Review
As of Q3 2019, Lazard Asset Management held 1,619 positions worth $60.9B, down 1.3% from $61.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.18B in Q3 2019, closing 152 positions and reducing 430 holdings. Its most notable exit was Altaba Inc, an estimated $238M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Genmab worth $34.3M.
- Lazard Asset Management's largest Q3 2019 buy was Genmab: 1,694,121 shares worth $34.3M.
- Lazard Asset Management added most to CSX Corp in Q3 2019, an estimated $487M increase.
- Lazard Asset Management's biggest Q3 2019 reduction was YPF, cutting an estimated $362M.
- Lazard Asset Management fully exited Altaba Inc in Q3 2019, selling an estimated $238M.
- Lazard Asset Management's ten largest holdings make up 24% of its $60.9B portfolio in Q3 2019.
- Lazard Asset Management opened 432 new positions and closed 152 in Q3 2019.
- Lazard Asset Management's portfolio value fell 1.3% quarter-over-quarter to $60.9B.
Based on Lazard Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.